Buffer selection and practical considerations

When water is the wrong diluent

For the majority of research-supply peptides, bacteriostatic water or sterile saline is an appropriate diluent — the peptide is soluble at the intended concentration, stable at neutral pH, and produces acceptable injection-site tolerability. But a handful of compounds break this pattern and require a specifically buffered diluent to work at all. The three distinctive cases in this catalog are NAD+, glutathione and (for some formulations) certain GH-secretagogue variants. In each case the reason for buffering is different: NAD+ has a stability-and-pH problem that produces injection-site pain if not buffered; glutathione is unstable at neutral pH and typically supplied in acidic or buffered formulations; specific research-supply GH-secretagogue formulations may include acetate buffer to maintain solubility. Understanding why a compound needs a specific diluent is what lets you match the labelling instruction to the underlying chemistry.

pH and injection-site tolerability

Human tissue tolerates injections best when the injected solution has a pH close to physiological (approximately 7.4). Solutions with pH far from this range cause a burning sensation on injection because the injected volume displaces local tissue pH transiently before it is buffered back to physiological range. Solutions with pH below approximately 5 or above approximately 8 are typically reported as significantly painful. NAD+ in aqueous solution has an unbuffered pH considerably below physiological — commonly cited around 3.5–4.5 depending on concentration — which is why an unbuffered NAD+ reconstitution produces the well-known injection-site pain associated with subcutaneous NAD+. The 'adjusted pH' formulations that are increasingly the standard for injectable NAD+ use a buffer (commonly phosphate or bicarbonate) to bring the solution pH closer to neutral, dramatically improving tolerability. The peptide molecule itself is the same; the difference is entirely in the buffered vehicle.

pH and peptide stability

Beyond tolerability, pH also affects peptide stability. Different amino-acid residues have different pH-dependent chemistry: aspartate can undergo isomerisation at neutral to basic pH, cysteine can oxidise more rapidly at basic pH, methionine can oxidise more rapidly at acidic pH, and hydrolytic cleavage of peptide bonds is generally minimised near neutral pH. For most peptides the stability optimum is close to physiological pH — which is convenient because it aligns with injection tolerability. But some compounds have specific pH optima that are not neutral. Glutathione is more stable in slightly acidic formulations because the reduced thiol form (which is the bioactive form) is more susceptible to oxidation to the disulphide form at higher pH. This explains why glutathione is commonly supplied in slightly acidic buffered vehicles rather than plain bacteriostatic water — the stability optimum is not at pH 7.4 for this compound.

Tonicity — an under-appreciated dimension

Tonicity is the effective osmolality of the injected solution relative to blood. Isotonic solutions (approximately 290 mOsm/kg) match blood; hypertonic solutions have higher osmolality; hypotonic solutions have lower osmolality. Injections of significantly hypertonic or hypotonic solutions cause local tissue effects — hypertonic solutions draw water out of surrounding cells, hypotonic solutions cause cells to swell — and produce burning or discomfort at the injection site. Bacteriostatic water and sterile water for injection are both hypotonic. Sterile saline (0.9% sodium chloride) is isotonic. For most peptide reconstitutions, the injected volume is small enough that the tonicity of the diluent does not produce clinically noticeable effects. But for larger-volume injections or for compounds delivered by intranasal or intraocular routes where tissue is more sensitive, tonicity becomes a design consideration. Compounded pharmacy formulations of peptides for intranasal use routinely use isotonic saline-based vehicles rather than bacteriostatic water for this reason.

Common questions